Suchergebnisse - "Vaduganathan, Muthiah"

PubPharm (908)

81

Missense Genetic Variation of ICAM1 and Incident Heart Failure

enthalten in: Journal of cardiac failure | 2023

von Giro, P. | Cunningham, J. | Rasmussen-Torvik, L. | +20

CommentIn: J Card Fail. 2023 Aug;29(8):1173-1174. - PMID 37062471

82

Examination of Initiation Patterns for Sacubitril/Valsartan Among Older Adults With HFrEF in the United States

enthalten in: JACC. Heart failure | 2023

von Bhatt, A. | Vaduganathan, M. | Lee, S. | +1

83

Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone

enthalten in: JAMA cardiology | 2023

von Agarwal, R. | Pitt, B. | Rossing, P. | +12

CommentIn: JAMA Cardiol. 2023 Aug 1;8(8):742-743. - PMID 37314793

84

Effects of newer kidney protective agents on kidney endpoints provide implications for future clinical trials

enthalten in: Kidney international | 2023

von Heerspink, H. | Jongs, N. | Neuen, B. | +9

CommentIn: Kidney Int. 2023 Sep;104(3):617. - PMID 37599021

85

Renal and blood pressure effects of dapagliflozin in recently hospitalized patients with heart failure with mildly reduced or preserved ejection fraction : Insights from the DELIVER trial

enthalten in: European journal of heart failure | 2023

von Chatur, S. | Cunningham, J. | Vaduganathan, M. | +16

86

Potential global impact of sodium-glucose cotransporter-2 inhibitors in heart failure

enthalten in: European journal of heart failure | 2023

von Talha, K. | Butler, J. | Greene, S. | +9

CommentIn: Eur J Heart Fail. 2023 Jul;25(7):1010-1011. - PMID 37218602

87

Optimizing Background Therapy for Heart Failure in Clinical Trials : Towards a More Objective Approach

enthalten in: JACC. Heart failure | 2023

von Desai, A. | Deswal, A. | McMurray, J. | +2

CommentOn: JACC Heart Fail. 2023 Jul;11(7):791-805. - PMID 37115135

88

Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk

enthalten in: JACC. Heart failure | 2023

von Khan, M. | Segar, M. | Usman, M. | +10

CommentIn: JACC Heart Fail. 2023 Jul;11(7):836-837. - PMID 37407157

89

Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes : Pooled Individual Participant Data From the CANVAS and CREDENCE Trials

enthalten in: Journal of the American Heart Association | 2023

von Fletcher, R. | Arnott, C. | Rockenschaub, P. | +15

90

Effect of dapagliflozin on health status and quality of life across the spectrum of ejection fraction : Participant-level pooled analysis from the DAPA-HF and DELIVER trials

enthalten in: European journal of heart failure | 2023

von Bhatt, A. | Kosiborod, M. | Vaduganathan, M. | +15